Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Editas Medicine, Inc. | EVP, CHIEF FINANCIAL OFFICER | Common Stock | 116,829 | $656 K | $5.61 | May 20, 2024 | Direct |
Editas Medicine, Inc. | EVP, CHIEF FINANCIAL OFFICER | Stock Option (right to buy) | 106,000 | Mar 2, 2024 | Direct | ||
Bone Biologics Corp | Director | Non-Employee Stock Option | 85,763 | Sep 18, 2023 | Direct | ||
Beyond Air, Inc. | Director | Stock Option (right to buy) | 45,000 | Mar 20, 2024 | Direct | ||
SAB Biotherapeutics, Inc. | Director | Employee Stock Option (right to buy) | 25,000 | Apr 3, 2023 | Direct | ||
AVEO PHARMACEUTICALS, INC. | Chief Financial Officer | Stock Option (Right to Buy) | 0 | Jan 19, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EDIT | Editas Medicine, Inc. | May 20, 2024 | 1 | -125,404 | 4 | May 22, 2024 | EVP, CHIEF FINANCIAL OFFICER |
XAIR | Beyond Air, Inc. | Mar 20, 2024 | 1 | 0 | 4 | Mar 21, 2024 | Director |
EDIT | Editas Medicine, Inc. | Mar 2, 2024 | 3 | 0 | 4 | Mar 5, 2024 | EVP, CHIEF FINANCIAL OFFICER |
BBLG | Bone Biologics Corp | Sep 18, 2023 | 1 | 0 | 4 | Sep 20, 2023 | Director |
EDIT | Editas Medicine, Inc. | May 17, 2023 | 2 | 0 | 4 | May 18, 2023 | EVP, CHIEF FINANCIAL OFFICER |
EDIT | Editas Medicine, Inc. | May 17, 2023 | 0 | 0 | 3 | May 18, 2023 | EVP, CHIEF FINANCIAL OFFICER |
SABS | SAB Biotherapeutics, Inc. | Apr 3, 2023 | 1 | 0 | 4 | Apr 5, 2023 | Director |
SABS | SAB Biotherapeutics, Inc. | Apr 3, 2023 | 0 | 0 | 3 | Apr 5, 2023 | Director |
XAIR | Beyond Air, Inc. | Mar 29, 2023 | 1 | 0 | 4 | Mar 31, 2023 | Director |
XAIR | Beyond Air, Inc. | Mar 16, 2023 | 1 | 13,634 | 4 | Mar 20, 2023 | Director |
AVEO | AVEO PHARMACEUTICALS, INC. | Jan 19, 2023 | 3 | 0 | 4 | Jan 19, 2023 | Chief Financial Officer |
BBLG | Bone Biologics Corp | Aug 23, 2022 | 1 | 0 | 4 | Mar 8, 2023 | Director |
XAIR | Beyond Air, Inc. | Mar 3, 2022 | 1 | 0 | 4 | Mar 7, 2022 | Director |
AVEO | AVEO PHARMACEUTICALS, INC. | Feb 15, 2022 | 1 | 0 | 4 | Feb 17, 2022 | Chief Financial Officer |
BBLG | Bone Biologics Corp | Oct 26, 2021 | 2 | 0 | 4 | Feb 28, 2022 | Director |
BBLG | Bone Biologics Corp | Oct 15, 2021 | 0 | 0 | 3 | Oct 21, 2021 | Director |